news details |
|
|
| Welcome Move | | | The government’s decision to introduce tighter regulatory control mandating that all syrups, including cough syrups, will need a doctor’s prescription before they are purchased is a welcome move.
Cough syrups are now be sold only on doctor’s prescription and with the omission of the word “syrup” the sale and dispensing of cough syrups in smaller villages will now be required to take place only through duly licensed pharmacies in accordance with the provisions of the Drugs and Cosmetics Act, 1940 and the Rules framed under it.
At a time when the misuse of certain cough formulations has become a growing concern, this move reflects a responsible effort to protect public health, prevent substance abuse, and ensure that medicines are used only for their intended therapeutic purposes.
For years, the easy availability of cough syrups containing habit-forming ingredients has contributed to their widespread misuse, especially among young people. What is meant to be a medicine for temporary relief from illness has, in many cases, become a source of addiction due to over-the-counter sales and weak regulatory oversight. The unrestricted sale of such products has not only endangered individual health but has also created wider social challenges linked to drug abuse.
The decision to require a valid doctor’s prescription before the purchase of cough syrups will serve as an important safeguard against indiscriminate consumption. It will encourage proper medical consultation and reduce the chances of self-medication, which often masks underlying illnesses and leads to inappropriate treatment. Responsible prescribing and dispensing practices are essential components of a safe healthcare system.
The benefits of this policy extend beyond preventing abuse. It will strengthen the accountability of the pharmaceutical supply chain, improve record-keeping, and ensure that medicines are dispensed by trained professionals who can advise patients on dosage, precautions, and possible side effects. Such safeguards are particularly important in rural and remote areas where healthcare awareness may be limited.
However, successful implementation will require more than just regulatory changes. Authorities must ensure adequate availability of licensed pharmacies, especially in underserved regions, so that genuine patients are not inconvenienced. Public awareness campaigns should educate citizens about the reasons behind the new restrictions and discourage self-medication. Medical practitioners and pharmacists must also be supported with clear guidelines to facilitate smooth compliance.
Strict enforcement against illegal sales, counterfeit medicines, and unauthorized vendors will be equally crucial. Regulatory agencies must conduct regular inspections and impose meaningful penalties on violators to ensure that the spirit of the reform is upheld. |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
 |
|
|
